These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30130521)

  • 1. Activity of paraoxonase 1 (PON1) on HDL
    Miljkovic M; Stefanovic A; Vekic J; Zeljkovic A; Gojkovic T; Simic-Ogrizovic S; Bogavac-Stanojevic N; Cerne D; Ilic J; Stefanovic I; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Kotur-Stevuljevic J
    Clin Biochem; 2018 Sep; 60():52-58. PubMed ID: 30130521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of paraoxonase 1 after hemodialysis is associated with HDL remodeling and its increase in the HDL2 fraction and VLDL.
    Gugliucci A; Kinugasa E; Ogata H; Caccavello R; Kimura S
    Clin Chim Acta; 2014 Mar; 430():9-14. PubMed ID: 24384301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
    Gugliucci A
    Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL Subclasses and the Distribution of Paraoxonase-1 Activity in Patients with ST-Segment Elevation Acute Myocardial Infarction.
    Djekic S; Vekic J; Zeljkovic A; Kotur-Stevuljevic J; Kafedzic S; Zdravkovic M; Ilic I; Hinic S; Cerovic M; Stefanovic M; Mihajlovic M; Neskovic A; Bogavac-Stanojevic N
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of lipid profile with serum PON1 concentration in patients with chronic kidney disease.
    Samouilidou E; Kostopoulos V; Liaouri A; Kioussi E; Vassiliou K; Bountou E; Grapsa E
    Ren Fail; 2016 Nov; 38(10):1601-1606. PubMed ID: 26888625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.
    Kalogerakis G; Baker AM; Christov S; Rowley KG; Dwyer K; Winterbourn C; Best JD; Jenkins AJ
    Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDL3-related decreased serum paraoxonase (PON) activity in uremic patients: comparison with the PON1 allele polymorphism.
    Schiavon R; Battaglia P; De Fanti E; Fasolin A; Biasioli S; Targa L; Guidi G
    Clin Chim Acta; 2002 Oct; 324(1-2):39-44. PubMed ID: 12204423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: in vivo and in vitro studies.
    Rosenblat M; Volkova N; Aviram M
    Biofactors; 2014; 40(5):536-45. PubMed ID: 25230879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.
    Liberopoulos EN; Papavasiliou E; Miltiadous GA; Cariolou M; Siamopoulos KC; Tselepis AD; Elisaf MS
    Perit Dial Int; 2004; 24(6):580-9. PubMed ID: 15559488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overweight and obesity in polycystic ovary syndrome: association with inflammation, oxidative stress and dyslipidaemia.
    Perovic Blagojevic IM; Vekic JZ; Macut DP; Ignjatovic SD; Miljkovic-Trailovic MM; Zeljkovic AR; Spasojevic-Kalimanovska VV; Bozic-Antic IB; Bjekic-Macut JD; Kastratovic-Kotlica BA; Andric ZG; Ilic DS; Kotur-Stevuljevic JM
    Br J Nutr; 2022 Aug; 128(4):604-612. PubMed ID: 34511137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins.
    Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S
    J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis.
    Gugliucci A; Kinugasa E; Kotani K; Caccavello R; Kimura S
    Clin Chem Lab Med; 2011 Jan; 49(1):61-7. PubMed ID: 20961187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased oxidized-LDL levels and arylesterase activity/HDL ratio in ESRD patients treated with hemodialysis.
    Mahrooz A; Zargari M; Sedighi O; Shaygani H; Gohari G
    Clin Invest Med; 2012 Jun; 35(3):E144-51. PubMed ID: 22673317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase 1 and HDL maturation.
    Gugliucci A; Menini T
    Clin Chim Acta; 2015 Jan; 439():5-13. PubMed ID: 25261854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study.
    Sutherland WH; de Jong SA; Walker RJ
    Nephrol Dial Transplant; 2004 Jan; 19(1):75-82. PubMed ID: 14671042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arylesterase activity of paraoxonase 1 (PON1) on HDL
    Valencia C SY; Isaza M CA; Henao B J; Beltrán A L; Loango N; Landázuri P
    Biochem Biophys Rep; 2021 Jul; 26():100971. PubMed ID: 33778169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of amino-terminal C-type natriuretic peptide serum level and its correlation with high-density lipoprotein structure and function in patients with end stage renal disease before and after kidney transplantation.
    Szentimrei R; Lőrincz H; Szentpéteri A; Varga VE; Seres I; Varga É; Nemes B; Harangi M; Paragh G
    Chem Biol Interact; 2023 Nov; 385():110749. PubMed ID: 37802408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anaerobic training on paraoxonase-1 enzyme (PON1) activities of high density lipoprotein subgroups and its relationship with PON1-Q192R phenotype.
    Turgay F; Şişman AR; Aksu AÇ
    J Atheroscler Thromb; 2015; 22(3):313-26. PubMed ID: 25735253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase 1 lactonase activity and distribution in the HDL subclasses in the cord blood.
    Gugliucci A; Numaguchi M; Caccavello R; Kimura S
    Redox Rep; 2014 May; 19(3):124-32. PubMed ID: 24620935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
    Rosenblat M; Karry R; Aviram M
    Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.